Preliminary Results of a New Treatment Strategy for Relapsed Left Ventricular Assist Device-Specific Infections

Ann Thorac Surg. 2020 Oct;110(4):1302-1307. doi: 10.1016/j.athoracsur.2020.02.007. Epub 2020 Mar 10.

Abstract

Background: Relapsed ventricular assist device-specific infections are associated with high morbidity, mortality, and hospital costs. A new combination of cold atmospheric plasma and special dressing technique with negative pressure wound therapy with an additional underlay of carbon cloth and hypochlorite rinsing solutions has been developed and reported in this study.

Methods: Between January 2016 and January 2018, 9 patients with relapsed infected driveline or pump pocket infection were treated with this new combined strategy. The primary endpoint was complete wound healing without recurrence of infection, defined as the presence at the same site within the first year after treatment. The secondary endpoint was control of infection, defined as a marked reduction of the infected area.

Results: After a median treatment time of 3 weeks, an immediate response was observed in all patients, and complete healing was achieved in 6 patients. Five patients met the primary endpoint, and infection did not recur after a median follow-up of 17.5 (range, 12.1 to 21.8) months. One patient underwent heart transplantation 6 months after successful wound treatment (complete wound healing). The remaining 3 patients were discharged with controlled infection. After a median follow-up of 5.7 months, 1 destination therapy patient died at home, and 2 patients underwent urgent heart transplantation because of recurrence of infection caused by Pseudomonas aeruginosa. Side effects were not observed.

Conclusions: The new combination treatment offers a promising option for patients with ventricular assist device-relapsed infection. Despite this, further studies are warranted to confirm those encouraging preliminary results.

MeSH terms

  • Adult
  • Aged
  • Atmospheric Pressure
  • Cohort Studies
  • Combined Modality Therapy
  • Female
  • Heart Failure / therapy*
  • Heart-Assist Devices / adverse effects*
  • Humans
  • Male
  • Middle Aged
  • Negative-Pressure Wound Therapy / methods*
  • Plasma Gases / therapeutic use*
  • Prosthesis-Related Infections / etiology
  • Prosthesis-Related Infections / therapy*
  • Recurrence
  • Treatment Outcome

Substances

  • Plasma Gases